The study conducted in 399 participants [all unvaccinated1See press release here.] met its primary efficacy endpoint with a reduction of 72% of COVID-19 infection in the group treated with daily oral administration of ivermectin compared to the placebo group
MedinCell
Might this tempt Alex Berenson?
Continue reading Proven again: ivermectin 72% effective in prevention of Covid-19 infection- 1